Edition:
Deutschland

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

65.84EUR
23 Sep 2019
Change (% chg)

€-1.39 (-2.07%)
Prev Close
€67.23
Open
€66.77
Day's High
€67.09
Day's Low
€65.66
Volume
323,898
Avg. Vol
3,258,126
52-wk High
€79.95
52-wk Low
€52.02

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

Company Address

Bayer AG

Kaiser-Wilhelm-Allee 1
LEVERKUSEN     51373
P: +49214.301
F: +49214.3066328

Company Web Links

Officers & Directors

Name Age Since Current Position

Werner Wenning

72 2012 Independent Chairman of the Supervisory Board

Werner Baumann

56 2016 Chairman of the Management Board, Chief Executive Officer

Oliver Zuehlke

50 2015 Independent Vice Chairman of the Supervisory Board, Employee Representative

Wolfgang Nickl

49 2018 Chief Financial Officer, Member of the Management Board

Hartmut Klusik

62 2016 Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director